ArticleFrontiers in pharmacology2025

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer.

Shuning Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.